165 related articles for article (PubMed ID: 16401937)
1. Platelet aggregometric study on whole blood of patients with ischaemic heart disease.
Lakhey M; Agarwal A; Badhe B
Kathmandu Univ Med J (KUMJ); 2005; 3(1):11-6. PubMed ID: 16401937
[TBL] [Abstract][Full Text] [Related]
2. Using the Platelet Function Analyzer-100 for monitoring aspirin therapy.
Poulsen TS; Mickley H; Korsholm L; Licht PB; Haghfelt T; Jørgensen B
Thromb Res; 2007; 120(2):161-72. PubMed ID: 17052745
[TBL] [Abstract][Full Text] [Related]
3. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
[TBL] [Abstract][Full Text] [Related]
4. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).
Dyszkiewicz-Korpanty A; Olteanu H; Frenkel EP; Sarode R
Platelets; 2007 Nov; 18(7):491-6. PubMed ID: 17852774
[TBL] [Abstract][Full Text] [Related]
6. Aspirin resistance in ischaemic heart disease.
Kuliczkowski W; Halawa B; Korolko B; Mazurek W
Kardiol Pol; 2005 Jan; 62(1):14-25. PubMed ID: 15815775
[TBL] [Abstract][Full Text] [Related]
7. Use of the platelet function analyser (PFA-100) to quantify the effect of low dose aspirin in patients with ischaemic heart disease.
Coakley M; Self R; Marchant W; Mackie I; Mallett SV; Mythen M
Anaesthesia; 2005 Dec; 60(12):1173-8. PubMed ID: 16288614
[TBL] [Abstract][Full Text] [Related]
8. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis?
von Lewinski F; Riggert J; Paulus W
J Stroke Cerebrovasc Dis; 2009; 18(2):111-5. PubMed ID: 19251186
[TBL] [Abstract][Full Text] [Related]
9. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
Velik-Salchner C; Maier S; Innerhofer P; Kolbitsch C; Streif W; Mittermayr M; Praxmarer M; Fries D
Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
11. Response to aspirin and clopidogrel monitored with different platelet function methods.
Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
[TBL] [Abstract][Full Text] [Related]
12. Aspirin failure course during exercise and its connection with soluble CD40L.
Kuliczkowski W; Kobusiak-Prokopowicz M; Prajs I; Karolko B; Mazurek W
Thromb Res; 2007; 119(6):679-86. PubMed ID: 16780932
[TBL] [Abstract][Full Text] [Related]
13. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
Violi F; Praticò D; Iuliano L; Balsano F
J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
[TBL] [Abstract][Full Text] [Related]
14. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests.
Shenkman B; Matetzky S; Fefer P; Hod H; Einav Y; Lubetsky A; Varon D; Savion N
Thromb Res; 2008; 122(3):336-45. PubMed ID: 18155752
[TBL] [Abstract][Full Text] [Related]
15. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study.
Watala C; Ulicna O; Golanski J; Nocun M; Waczulíková I; Markuszewski L; Drzewoski J
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):113-24. PubMed ID: 16479193
[TBL] [Abstract][Full Text] [Related]
16. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
[TBL] [Abstract][Full Text] [Related]
17. High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes.
Cuisset T; Frere C; Quilici J; Morange PE; Nait-Saidi L; Mielot C; Bali L; Lambert M; Alessi MC; Bonnet JL
Thromb Haemost; 2007 Feb; 97(2):282-7. PubMed ID: 17264958
[TBL] [Abstract][Full Text] [Related]
18. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
[TBL] [Abstract][Full Text] [Related]
19. To adjust or not to adjust the platelet count in light transmission aggregometry in patients receiving dual aspirin/clopidogrel treatment.
van der Stelt CA; van Werkum JW; Seesing TH; Berg JM; Hackeng CM
Platelets; 2007 Nov; 18(7):550-3. PubMed ID: 17957573
[TBL] [Abstract][Full Text] [Related]
20. Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD).
Meade TW; Cooper JA; Miller GJ
Thromb Haemost; 1997 Aug; 78(2):926-9. PubMed ID: 9268196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
